ClearOne Inc (NASDAQ:CLRO) does about 277.12K shares in volume on a normal day but saw 4774730 shares change hands in the recent trading day. The company now has a market cap of 41.26M USD. Its current market price is $1.31, marking an increase of 31.39% compared to the previous close of $1.00. The 52 week high reached by this stock is $1.70 whilst the lowest price level in 52 weeks is $0.46.
ClearOne Inc (CLRO) has a 20-day trading average at $0.6501 and the current price is -22.94% off the 52-week high compared with 187.91% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.5817 and its 200-day simple moving average is $0.7544. If we look at the stock’s price movements over the week, volatility stands at 34.29%, which decreases to 14.17% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 90.82 to suggest the stock is overbought.
The consensus objective for the share price is $4.00, suggesting that the stock has a potential upside of 67.25% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on August 16, 2018 when Singular Research reiterated the stock to “BUY – Long-Term” and issued a price target of between $4 and $6.
The current price level is 101.49%, 125.22%, and 83.44% away from its SMA20, SMA50, and SMA200 respectively, with the CLRO price moving below the 50-day SMA on current market day. ClearOne Inc (CLRO) stock is up 122.03% over the week and 162.00% over the past month. Its price is 67.43% year-to-date and 78.59% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year.
To reach the target analysts have set, the stock logically needs to grow 67.25 percent from here.
Outstanding shares total 23.97M with insiders holding 48.42% of the shares and institutional holders owning 5.81% of the company’s common stock. The company has a return on investment of -17.26% and return on equity of -12.63%. The beta has a value of 0.73. Price to book ratio is 1.34 and price to sales ratio is 3.28.
